Apology accepted and likewise. Yes, it's a shareholding, just...

Apology accepted and likewise.

Yes, it's a shareholding, just like my shareholding in AHZ which does not make a profit and requires shareholders to fund it (time and time and time again).

I'm not saying that anything dodgy was happening with the immunotherapies entity. I have just been curious how much money was left in the immunotherapy entity's accounts. Inevitably AHZ would have to put more money into it, my question was when could this be expected? The deal with Star Bright (if it closes) will get rid of AHZ's needs to provide any funding for a long time.

The main point I was trying to get to in discussing this was that I hope there would be no cash calls from immunotherapies to provide funding before the deal with Star Bright closes. But at this stage I guess this is like looking for my misplaced umbrella whilst being a passenger on the Titanic.